期刊文献+

不同方式的干预措施对糖耐量受损患者的影响 被引量:7

Effect of intervention measurements of various patterns in patients with impaired glucose tolerance
下载PDF
导出
摘要 目的:探讨糖耐量受损患者不同方式干预措施的临床效果。方法:对112例糖耐量受损患者分别采用安慰剂、行为干预、药物、行为干预加药物治疗的措施,均达1年以上,监测人体质量指数、空腹血糖、餐后2 h血糖、糖基化血红蛋白变化。结果:对照组在给予安慰剂治疗1年后,人体质量指数、空腹血糖、餐后2 h血糖、糖基化血红蛋白有上升趋势,但差异无统计学意义(P>0.05);行为干预组及药物治疗组在干预治疗1年后,人体质量指数、空腹血糖、餐后2 h血糖、糖基化血红蛋白等均有不同程度的下降,但差异亦无统计学意义(P>0.05);行为干预加药物治疗组人体质量指数、空腹血糖、餐后2 h血糖、糖基化血红蛋白明显下降,差异有统计学意义(P<0.05)。结论:糖耐量受损患者在控制饮食、坚持体育运动基础上,有必要结合药物干预治疗。 Objective To investigate the clinical effect of various intervention measurements in the patients with impaired glucose tolerance. Methods One hundred and twelve patients with impaired glucose tolerance were randomly divided into 4 groups, intervened with placebo, behavior intervention, drug, both behavior intervention and drug over 1 year respectively. The changes of BMI, fast blood glucose, and 2-hour post-prandial blood glucose and HbAlc were examined. Results The indexes including BMI, fast blood glucose, 2-hour post-prandial blood glucose and HbAlc in control group were higher than before. The indexes in behavior intervention group and drug group were lower after intervention measurements than before, but there was no statistic significant difference(P〉0. 05). While they were significantly decreased and there was a significant difference in both behavior intervention and drug group after intervention measurements than before(P〈0. 05). Conclusion Behavior intervention combined with drug therapy will benefit patients with impaired glucose tolerance.
出处 《实用诊断与治疗杂志》 2007年第4期269-270,共2页 Journal of Practical Diagnosis and Therapy
关键词 糖尿病 糖耐量受损 行为 药物 干预 Diabetes mellitus impaired glucose tolerance behaviour drug intervention
  • 相关文献

参考文献7

二级参考文献23

  • 1李慧,邹大进,张乐之,高从容,贾莺歌.血清抵抗素水平与肥胖及2型糖尿病的关系[J].中国糖尿病杂志,2004,12(3):199-201. 被引量:25
  • 2潘长玉 陆菊平 等.首都钢铁公司成年人群糖尿病患病率调查[J].中华医学杂志,1995,75:409-411.
  • 3Prigeon R J,Jacobson R K,Porte D,et al. Effect of sulfonylurea withdrawal on proinsulin levels, B-cell function, and glucose disposal in subjects with non-insulin-dependent diabetes mellitus[J]. J Clin Endocrinol Metab,1996,81:3295.
  • 4Davies M J,Metcalfe J,Day J L,et al. Effect of sulphonylurea therapy on plasma insulin, intact ang 32/33. split proinsulin in subjects with type 2 diabetes mellitus[J]. Diabet Med, 1994,11:293.
  • 5Raehman J, Levy J C, Barrow B A, et al. Relative yperproinsulinemia of NIDDM persists despite the reduetion of hyperglycemia with insulin or sulfonylurea therapy[J]. Diabetes,1997,46:1557.
  • 6Stone L M,Kahn S E,Fujimoto W Y,et al. A variation at position 30 of the B-cell gluckonase gene promoter is associated with reduced b-cell function in middle-aged Japaness-American men[J]. Diabetes, 1999,45 : 42.
  • 7Holman R R,Robert Turner,Rury Holman, et al. UKPDS Study[J]. Diabetes Care, 1999,22 : 966.
  • 8Del Prato S, Tiengo A. The importance of first-phase insulin secretion :implications for the therapy of type 2 diabetes mellitus[J]. Diabetes Metab Res Rev,2001,17(3) : 164.
  • 9向红丁,中国糖尿病杂志,1998年,6卷,131页
  • 10Pan X R,Diabetes Care,1997年,20卷,537页

共引文献182

同被引文献79

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部